Top News Investor Relations DISCLOSEABLE TRANSACTION IN RELATION TO CAPITAL INJECTION AND ACQUISITION OF APPROXIMATELY 22.9% OF

DISCLOSEABLE TRANSACTION IN RELATION TO CAPITAL INJECTION AND ACQUISITION OF APPROXIMATELY 22.9% OF

2022-07-28